Hey everyone, Just wanted to share an important message that Jeff Cohen put out from their firm's TikTok account this morning. For those who don't know, Jeff represents some major companies in the peptide space, so when he speaks, it's worth paying attention. Please watch the full video - I don't like to put words in anyone's mouth, and the full context matters here. From what I'm seeing, my assumptions seem to be correct that something bigger is coming. This isn't just about FDA 66-80 or the SAFE Drug Act - there appears to be something specifically targeting the research space as well. I know regulatory uncertainty is stressful for all of us, but staying informed is our best defense. As always, I will keep everyone in the loop as I learn more. Drop your thoughts below after watching 👇

I've been digging through every piece of legislation I can find. This one is different. The SAFE Drug Act was introduced November 19th and it's clearly written to kill compounded GLP-1s: → 20 compounded prescriptions per month. That's it. Total. → New definition of "essentially a copy" that captures almost every semaglutide and tirzepatide script → Mandatory FDA reporting for out-of-state compounding (aka the entire telehealth model) → 503B outsourcing facilities get hit with pharma-level oversight → Uncapped FDA fees This is different from Import Alert 66-80. That one creates supply friction. This one makes the business model illegal. BUT—and this is important—this still doesn't explain what's happening in the research space. This bill targets compounding pharmacies, not research companies. So why are vendors liquidating and pointing to 12/31? There's something else out there I haven't found yet. Full breakdown of every section of the bill 👇 https://open.substack.com/pub/derekpruski/p/the-safe-drug-act-the-compounding?r=4jq1x8&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

I promised to keep everyone updated with what's going on with this GLP-1 situation 12/31. Here is the message Atomik and Solution wants to relay to everyone, to be clear there is no new info here they just wanted to address their action plan: We have been made aware of the potential changes to the landscape regarding the selling of research use GLP's. With compliance in mind, we're offering a huge sale on ALL GLP's, while supplies last, as these items may not be available for purchase from us after December 31st. Should this be true, Atomik Labz is committed to adhering to all standards and guidelines in an ever changing industry. What We're Doing: Atomik Labz is offering a HUGE BUY ONE, GET ONE FREE SALE on all GLP singles and packs AND SS-31. We're also offering 25% off everything else, SITE-WIDE. This sale is live until supplies last. Use Code Derek25 for everything besides the BOGO Free. GLP PRICE SLASHES — BUY SINGLES AND SAVE EVEN MORE! Contact us for custom bulk pricing. GLP-1 - 5mg: $59 → $49 + BOGO FREE - 10mg: $99 → $79 + BOGO FREE GLP-2 - 60mg: $299 → $250 + BOGO FREE - 120mg: $549 → $399 + BOGO FREE GLP-3 - 10mg: $99 → $89 + BOGO FREE - 24mg: $199 → $159 + BOGO FREE - 40mg: $346 → $250 + BOGO FREE - 60mg: $544 → $350 + BOGO FREE 🔥 25% OFF SITEWIDE - Code: DEREK25 🎁 BOGO: All GLPs (sema/tirz/reta) + SS-31 (Can't stack code with BOGO items) 🏃‍♂️ THE SS-31 STEAL SS-31 50mg = $159 BOGO = 100mg for $159 = $1.59/mg I convinced them to add SS-31 to the BOGO specifically for you all. This is INSANE pricing. 🎁 $2,500 GIVEAWAY 10 winners get their order FREE. To Enter: 1. Order during sale 2. Leave review at https://peptideprice.store/reviews LINKS: 🔗 Atomik Labz: https://atomiklabz.com/aff/51/ 🔗 Solution Peptides: https://solutionpeptides.net/aff/51/ 🔗 Compare Here: https://peptideprice.store

Everyone's losing their minds over Eli Lilly doomsday scenarios - generic tirz flooding the market, potential crackdowns, the research peptide space collapsing, etc. Here's something interesting: Eli Lilly doesn't own survodutide. Boehringer Ingelheim does. So even if every single worst-case scenario about sema, tirz, and reta comes true... survodutide operates in a completely different corporate universe with different timelines, different patents, different legal strategies. Different company = different dynamics = different risks. Just something to keep in mind when everyone's panicking about one pharmaceutical giant. The peptide space isn't a monolith, and not every compound is tied to the same corporate fate. This isn't investment or medical advice - just pointing out that the industry has more moving pieces than people realize. What are your thoughts? Are people too focused on Eli Lilly and missing the bigger picture?

Quick clarification, I get asked about a lot 👇 “Do Atomik Labz and Solution Peptides actually carry Hospira bac water, or is that BS?” Short answer: yes — it’s legitimate. It's a 3d render, that's why it looks different. Longer answer: They cannot legally label it as “Hospira” due to branding and distribution restrictions, but the source and manufacturing match Hospira’s bacteriostatic water. This is why the labeling looks different, but the product itself is not some knockoff or substitute. If you know how this industry works, this isn’t unusual — it’s about labeling compliance, not product quality. 🔥 Current Deal If you’re looking to stock up, code derek25 is active right now and brings the price down to $8.99. Direct product links: - https://atomiklabz.com/product/30ml-bac-water-reconstitution-solution/?aff=51 - https://solutionpeptides.net/product/bac-water-30ml/aff/51/ Full sites: - 🔗 https://atomiklabz.com/aff/51/ - 🔗 https://solutionpeptides.net/aff/51/ 🚨 Don’t Miss the Sale - BOGO GLP-1s - SS-31 included - Note: BOGO does not stack with derek25 ⚠️ Reminder: All products mentioned are for RESEARCH USE ONLY and NOT FOR HUMAN CONSUMPTION. If you have questions, drop them below — happy to clear it up.